WallStreetZenWallStreetZen

NASDAQ: SRDX
Surmodics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their SRDX stock forecasts and price targets.

Forecast return on equity

Is SRDX forecast to generate an efficient return?

Company
3.63%
Industry
22.54%
Market
-20.15%
SRDX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SRDX forecast to generate an efficient return on assets?

Company
2.45%
Industry
11.89%
SRDX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SRDX earnings per share forecast

What is SRDX's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.30
Avg 2 year Forecast
-$0.12
Avg 3 year Forecast
$0.28

SRDX revenue forecast

What is SRDX's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$117.7M-3.17%
Avg 2 year Forecast
$122.0M+0.36%
Avg 3 year Forecast
$129.0M+6.11%
SRDX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SRDX revenue growth forecast

How is SRDX forecast to perform vs Medical Devices companies and vs the US market?

Company
0.55%
Industry
7.16%
Market
11.9%
SRDX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SRDX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SRDX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
SRDX$32.37N/AN/A
TMCI$7.22$6.83-5.36%Hold
VREX$11.48$16.00+39.37%Strong Buy
CBLL$11.95$32.00+167.78%Strong Buy
KIDS$19.56$34.50+76.38%Strong Buy
View Top Medical Device Stocks

Surmodics Stock Forecast FAQ

What is SRDX's earnings growth forecast for 2025-2027?

(NASDAQ: SRDX) Surmodics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 16.94%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.33%.

Surmodics's earnings in 2025 is -$19,863,000.On average, 2 Wall Street analysts forecast SRDX's earnings for 2025 to be -$4,289,780, with the lowest SRDX earnings forecast at -$4,289,780, and the highest SRDX earnings forecast at -$4,289,780. On average, 2 Wall Street analysts forecast SRDX's earnings for 2026 to be -$1,715,912, with the lowest SRDX earnings forecast at -$1,715,912, and the highest SRDX earnings forecast at -$1,715,912.

In 2027, SRDX is forecast to generate $4,003,794 in earnings, with the lowest earnings forecast at $4,003,794 and the highest earnings forecast at $4,003,794.

If you're new to stock investing, here's how to buy Surmodics stock.

What is SRDX's revenue growth forecast for 2025-2027?

(NASDAQ: SRDX) Surmodics's forecast annual revenue growth rate of 0.55% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.9%.

Surmodics's revenue in 2025 is $121,575,000.On average, 2 Wall Street analysts forecast SRDX's revenue for 2025 to be $1,683,309,594, with the lowest SRDX revenue forecast at $1,681,307,696, and the highest SRDX revenue forecast at $1,685,311,491. On average, 2 Wall Street analysts forecast SRDX's revenue for 2026 to be $1,744,653,445, with the lowest SRDX revenue forecast at $1,730,354,179, and the highest SRDX revenue forecast at $1,758,952,711.

In 2027, SRDX is forecast to generate $1,844,676,810 in revenue, with the lowest revenue forecast at $1,831,306,997 and the highest revenue forecast at $1,858,046,624.

What is SRDX's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: SRDX) forecast ROA is 2.45%, which is lower than the forecast US Medical Devices industry average of 11.89%.

What is SRDX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SRDX) Surmodics's current Earnings Per Share (EPS) is -$1.40. On average, analysts forecast that SRDX's EPS will be -$0.30 for 2025, with the lowest EPS forecast at -$0.30, and the highest EPS forecast at -$0.30. On average, analysts forecast that SRDX's EPS will be -$0.12 for 2026, with the lowest EPS forecast at -$0.12, and the highest EPS forecast at -$0.12. In 2027, SRDX's EPS is forecast to hit $0.28 (min: $0.28, max: $0.28).

What is SRDX's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: SRDX) forecast ROE is 3.63%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.